Browsing: Gilead

Sundry Images/iStock Editorial through Getty Photographs Gilead Sciences (NASDAQ:GILD) has accomplished its $4.3B acquisition of CymaBay Therapeutics (NASDAQ:CBAY). Nonetheless, the…

jurgenfr Gilead Sciences (NASDAQ:GILD) is predicted to report the next This autumn revenue on decrease income Tuesday night, with buyers…

Sundry Images Arcus Biosciences (NYSE:RCUS) shares jumped 16% in post-market buying and selling Monday following information that accomplice Gilead Sciences…